Adicet Bio (ACET) Construction in Progress (2020 - 2024)
Adicet Bio (ACET) posted quarterly Construction in Progress of $100000.0 for Q4 2024, down 98.89% year-over-year from $9.0 million in Q1 2024, and down 98.89% quarter-over-quarter from $9.0 million in Q4 2023.
Adicet Bio (ACET) Construction in Progress (2020 - 2024) Analysis & Trends
Adicet Bio's Construction in Progress history runs 5 years deep, the most recent figure standing at $100000.0 for Q4 2024.
- In Q4 2024, Construction in Progress fell 98.89% year-over-year to $100000.0; the TTM figure through Dec 2024 stood at $100000.0 (down 98.89% YoY), while the FY2024 annual figure was $100000.0, down 98.89% from the prior year.
- Construction in Progress for Q4 2024 stood at $100000.0, down from $9.0 million in the prior quarter.
- The five-year high for Construction in Progress was $9.3 million in Q4 2022, with the low at $100000.0 in Q4 2024.
- The 5-year median for Construction in Progress is $1.6 million (2023), against an average of $3.1 million.
- The sharpest annual moves came in 2023 and 2024: Construction in Progress retreated 3.23% in 2023, then slumped 98.89% in 2024.
- Adicet Bio's Construction in Progress stood at $1.2 million in 2020, then tumbled by 38.66% to $730000.0 in 2021, then soared by 1173.97% to $9.3 million in 2022, then dropped by 3.23% to $9.0 million in 2023, then plunged by 98.89% to $100000.0 in 2024.
- Business Quant data shows ACET's Construction in Progress at $100000.0 in Q4 2024, $9.0 million in Q4 2023, and $500000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Adicet Bio | 98.21 Mn | -19.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 9.30 Mn |
| Mar 31, 2021 | 730,000.00 |
| Dec 31, 2020 | 1.19 Mn |
| Sep 30, 2020 | 3.49 Mn |